Blood lead level and measured glomerular filtration rate in children with chronic kidney disease

Environmental Health Perspectives

Volumn 121, Issue 8, 2013, Pages 965-970

  Fadrowski, Jeffrey J ^a,b   Abraham, Alison G ^c   Navas Acien, Ana ^b,c   Guallar, Eliseo ^a,b,c,d   Weaver, Virginia M ^a,b,c   Furth, Susan L ^e  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^d CENTRO NACIONAL DE INVESTIGACIONES CARDIOVASCULARES CNIC   (Spain)

^e UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Children; Chronic kidney disease; Kidney; Lead; Nephrotoxicity; Pediatric

Indexed keywords

CADMIUM; IOHEXOL;

ADOLESCENT; ADULT; ANEMIA; ARTICLE; BODY MASS; CHRONIC KIDNEY DISEASE; CREATININE BLOOD LEVEL; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; FEMALE; GLOMERULUS FILTRATION RATE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HISPANIC; HUMAN; INFANT; LEAD BLOOD LEVEL; LINEAR REGRESSION ANALYSIS; MALE; MASS SPECTROMETRY; NEWBORN; POVERTY; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN URINE LEVEL; PROTEINURIA; SCHOOL CHILD; SENSITIVITY ANALYSIS;

ADOLESCENT; CANADA; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; CROSS-SECTIONAL STUDIES; ENVIRONMENTAL POLLUTANTS; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; INFANT; IOHEXOL; LEAD; MALE; PROSPECTIVE STUDIES; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS; UNITED STATES; YOUNG ADULT;

EID: 84880966887     PISSN: 00916765     EISSN: 15529924     Source Type: Journal    
DOI: 10.1289/ehp.1205164     Document Type: Article

References (62)

1. Åkesson A, Lundh T, Vahter M, Bjellerup P, Lidfeldt J, Nerbrand C, et al. 2005. Tubular and glomerular kidney effects in Swedish women with low environmental cadmium exposure. Environ Health Perspect 113:1627-1631.
2. Apostolou A, Garcia-Esquinas E, Fadrowski JJ, McClaine P, Weaver VM, Navas-Acien A. 2011. Secondhand tobacco smoke: a source of lead exposure in US children and adolescents. Am J Public Health 102(4):714-722; doi:10.2105/AJPH.2011.300161.
3. Ardissino G, Testa S, Daccò V, Viganò S, Taioli E, Claris-Appiani A, et al. 2004. Proteinuria as a predictor of disease progression in children with hypodysplastic nephropathy. Data from the Ital Kid Project. Pediatr Nephrol 19(2):172-177.
4. ATSDR (Agency for Toxic Substances and Disease Registry). 2007. Toxicological Profile for Lead. Available: http://www.atsdr.cdc.gov/ToxProfiles/tp.asp?id=96&tid=22 [accessed 1 March 2012].
5. CDC (Centers for Disease Control and Prevention). 2009. Fourth National Report on Human Exposure to Environmental Chemicals. Available: http://www.cdc.gov/exposurereport [accessed 29 February 2012].
6. CDC (Centers for Disease Control and Prevention). 2012a. Healthy Weight: Body Mass Index. Available: http://www.cdc.gov/nccdphp/dnpa/healthyweight/assessing/bmi/index.htm [accessed 1 March 2012].
7. CDC (Centers for Disease Control and Prevention). 2012b. The Fourth National Report on Human Exposure to Environmental Chemicals, Updated Tables, February 2012. Available: http://www.cdc.gov/exposurereport/pdf/FourthReport_UpdatedTables_Feb2012.pdf [accessed 27 May 2012].
8. Clayton CA, Pellizzari ED, Whitmore RW, Perritt RL, Quackenboss JJ. 1999. National Human Exposure Assessment Survey (NHEXAS): distributions and associations of lead, arsenic and volatile organic compounds in EPA region 5. J Expo Anal Environ Epidemiol 9(5):381-392.
9. Copelovitch L, Warady BA, Furth SL. 2011. Insights from the Chronic Kidney Disease in Children (CKiD) study. Clin J Am Soc Nephrol 6(8):2047-2053.
10. de Burbure C, Buchet JP, Leroyer A, Nisse C, Haguenoer JM, Mutti A, et al. 2006. Renal and neurologic effects of cadmium, lead, mercury, and arsenic in children: evidence of early effects and multiple interactions at environmental exposure levels. Environ Health Perspect 114:584-590.
11. deSilva PE. 1984. Blood lead levels and the haematocrit correction. Ann Occup Hyg 28(4):417-428.
12. Ekong EB, Jaar BG, Weaver VM. 2006. Lead-related nephrotoxicity: a review of the epidemiologic evidence. Kidney Int 70(12):2074-2084.
13. Evans M, Elinder CG. 2011. Chronic renal failure from lead: myth or evidence-based fact? Kidney Int 79(3):272-279.
14. Fadrowski JJ, Navas-Acien A, Tellez-Plaza M, Guallar E, Weaver VM, Furth SL. 2010. Blood lead level and kidney function in US adolescents: the Third National Health and Nutrition Examination Survey. Arch Intern Med 170(1):75-82.
15. Fadrowski JJ, Neu AM, Schwartz GJ, Furth SL. 2011. Pediatric GFR estimating equations applied to adolescents in the general population. Clin J Am Soc Nephrol 6(6):1427-1435.
16. Fadrowski JJ, Pierce CB, Cole SR, Moxey-Mims M, Warady BA, Furth SL. 2008. Hemoglobin decline in children with chronic kidney disease: baseline results from the chronic kidney disease in children prospective cohort study. Clin J Am Soc Nephrol 3(2):457-462.
17. Furth SL, Cole SR, Moxey-Mims M, Kaskel F, Mak R, Schwartz G, et al. 2006. Design and methods of the Chronic Kidney Disease in Children (CKiD) prospective cohort study. Clin J Am Soc Nephrol 1(5):1006-1015.
18. GISEN Group (Gruppo Italiano di Studi Epidemiologici in Nefrologia). 1997. Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy. Lancet 349(9069):1857-1863.
19. Hu H, Rabinowitz M, Smith D. 1998. Bone lead as a biological marker in epidemiologic studies of chronic toxicity: conceptual paradigms. Environ Health Perspect 106:1-8.
20. Inglis JA, Henderson DA, Emmerson BT. 1978. The pathology and pathogenesis of chronic lead nephropathy occurring in Queensland. J Pathol 124(2):65-76.
21. Khalil-Manesh F, Gonick HC, Cohen AH, Alinovi R, Bergamaschi E, Mutti A, et al. 1992. Experimental model of lead nephropathy. I. Continuous high-dose lead administration. Kidney Int 41(5):1192-1203.
22. Kim R, Rotnitsky A, Sparrow D, Weiss S, Wager C, Hu H. 1996. A longitudinal study of low-level lead exposure and impairment of renal function. The Normative Aging Study. JAMA 275(15):1177-1181.
23. Kim Y, Lee BK. 2012. Increased erythrocyte lead levels correlate with decreased hemoglobin levels in the Korean general population: analysis of 2008-2010 Korean National Health and Nutrition Examination Survey data. Int Arch Occup Environ Health; doi:10.1007/s00420-012-0811-3 [Online 23 August 2012].
24. Lanphear BP, Burgoon DA, Rust SW, Eberly S, Galke W. 1998. Environmental exposures to lead and urban children's blood lead levels. Environ Res 76(2):120-130.
25. Levin R, Brown MJ, Kashtock ME, Jacobs DE, Whelan EA, Rodman J, et al. 2008. Lead exposures in U.S. children, 2008: implications for prevention. Environ Health Perspect 116:1285-1293.
26. Lin C, Kim R, Tsaih SW, Sparrow D, Hu H. 2004. Determinants of bone and blood lead levels among minorities living in the Boston area. Environ Health Perspect 112:1147-1151.
27. Lin JL, Lin-Tan DT, Hsu KH, Yu CC. 2003. Environmental lead exposure and progression of chronic renal diseases in patients without diabetes. N Engl J Med 348(4):277-286.
28. Lin JL, Lin-Tan DT, Li YJ, Chen KH, Huang YL. 2006. Low-level environmental exposure to lead and progressive chronic kidney diseases. Am J Med 119(8):707. e1-707. e9.
29. Lin JL, Tan DT, Hsu KH, Yu CC. 2001. Environmental lead exposure and progressive renal insufficiency. Arch Intern Med 161(2):264-271.
30. Lin-Tan DT, Lin JL, Yen TH, Chen KH, Huang YL. 2007. Long-term outcome of repeated lead chelation therapy in progressive non-diabetic chronic kidney diseases. Nephrol Dial Transplant 22(10):2924-2931.
31. Litwin M. 2004. Risk factors for renal failure in children with non-glomerular nephropathies. Pediatr Nephrol 19(2):178-186.
32. Moel DI, Sachs HK. 1992. Renal function 17 to 23 years after chelation therapy for childhood plumbism. Kidney Int 42(5):1226-1231.
33. Muntner P, He J, Vupputuri S, Coresh J, Batuman V. 2003. Blood lead and chronic kidney disease in the general United States population: results from NHANES III. Kidney Int 63(3):1044-1050.
34. Muntner P, Menke A, DeSalvo KB, Rabito FA, Batuman V. 2005. Continued decline in blood lead levels among adults in the United States: the National Health and Nutrition Examination Surveys. Arch Intern Med 165(18):2155-2161.
35. National Center for Health Statistics. 2012. National Health and Nutrition Examination Survey, 2003-2004. Available: http://www.cdc.gov/nchs/nhanes/nhanes2003-2004/nhanes03_04.htm [accessed 1 March 2012].
36. National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents. 2004. The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics 114(2 suppl 4th report):555-576.
37. Navas-Acien A, Tellez-Plaza M, Guallar E, Muntner P, Silbergeld E, Jaar B, et al. 2009. Blood cadmium and lead and chronic kidney disease in US adults: a joint analysis. Am J Epidemiol 170(9):1156-1164.
38. Payton M, Hu H, Sparrow D, Weiss ST. 1994. Low-level lead exposure and renal function in the Normative Aging Study. Am J Epidemiol 140(9):821-829.
39. Peterson JC, Adler S, Burkart JM, Greene T, Hebert LA, Hunsicker LG, et al. 1995. Blood pressure control, proteinuria, and the progression of renal disease. The Modification of Diet in Renal Disease Study. Ann Intern Med 123(10):754-762.
40. Poggio ED, Wang X, Greene T, Van Lente F, Hall PM. 2005. Performance of the modification of diet in renal disease and Cockcroft-Gault equations in the estimation of GFR in health and in chronic kidney disease. J Am Soc Nephrol 16(2):459-466.
41. Rodriguez-Iturbe B, Sindhu RK, Quiroz Y, Vaziri ND. 2005. Chronic exposure to low doses of lead results in renal infiltration of immune cells, NF-κB activation, and overexpression of tubulointerstitial angiotensin II. Antioxid Redox Signal 7(9-10):1269-1274.
42. Rule AD, Larson TS, Bergstralh EJ, Slezak JM, Jacobsen SJ, Cosio FG. 2004. Using serum creatinine to estimate glomerular filtration rate: accuracy in good health and in chronic kidney disease. Ann Intern Med 141(12):929-937.
43. Schwartz GJ, Brion LP, Spitzer A. 1987. The use of plasma creatinine concentration for estimating glomerular filtration rate in infants, children, and adolescents. Pediatr Clin North Am 34(3):571-590.
44. Schwartz GJ, Furth S, Cole SR, Warady B, Munoz A. 2006. Glomerular filtration rate via plasma iohexol disappearance: pilot study for chronic kidney disease in children. Kidney Int 69(11):2070-2077.
45. Schwartz GJ, Haycock GB, Spitzer A. 1976. Plasma creatinine and urea concentration in children: normal values for age and sex. J Pediatr 88(5):828-830.
46. Schwartz GJ, Muñoz A, Schneider MF, Mak RH, Kaskel F, Warady BA, et al. 2009. New equations to estimate GFR in children with CKD. J Am Soc Nephrol 20(3):629-637.
47. Skerfving S, Bergdahl IA. 2007. Lead. In: Handbook on The Toxicology of Metals, 3rd ed. (Nordberg GF, Fowler BA, Nordberg M, Friberg LT, eds). London:Academic Press, 599-643.
48. Spector JT, Navas-Acien A, Fadrowski J, Guallar E, Jaar B, Weaver VM. 2011. Associations of blood lead with estimated glomerular filtration rate using MDRD, CKD-EPI and serum cystatin C-based equations. Nephrol Dial Transplant 26(9):2786-2792.
49. Staessen JA, Lauwerys RR, Buchet JP, Bulpitt CJ, Rondia D, Vanrenterghem Y, et al. 1992. Impairment of renal function with increasing blood lead concentrations in the general population. The Cadmibel Study Group. N Engl J Med 327(3):151-156.
50. Staessen JA, Nawrot T, Hond ED, Thijs L, Fagard R, Hoppenbrouwers K, et al. 2001. Renal function, cytogenetic measurements, and sexual development in adolescents in relation to environmental pollutants: a feasibility study of biomarkers. Lancet 357(9269):1660-1669.
51. Staples A, LeBlond R, Watkins S, Wong C, Brandt J. 2010. Validation of the revised Schwartz estimating equation in a predominantly non-CKD population. Pediatr Nephrol 25(11):2321-2326.
52. Steenland K, Selevan S, Landrigan P. 1992. The mortality of lead smelter workers: an update. Am J Public Health 82(12):1641-1644.
53. Stevens LA, Coresh J, Feldman HI, Greene T, Lash JP, Nelson RG, et al. 2007. Evaluation of the modification of diet in renal disease study equation in a large diverse population. J Am Soc Nephrol 18(10):2749-2757.
54. Tsaih SW, Korrick S, Schwartz J, Amarasiriwardena C, Aro A, Sparrow D, et al. 2004. Lead, diabetes, hypertension, and renal function: the Normative Aging Study. Environ Health Perspect 112:1178-1182.
55. U.S. Department of Health and Human Services. 2009. The 2009 HHS Poverty Guidelines. Available: http://aspe.hhs.gov/poverty/09poverty.shtml [accessed 1 March 2012].
56. Vaziri ND. 2008. Mechanisms of lead-induced hypertension and cardiovascular disease. Am J Physiol Heart Circ Physiol 295(2):H454-H465.
57. Wedeen RP, Malik DK, Batuman V. 1979. Detection and treatment of occupational lead nephropathy. Arch Intern Med 139(1):53-57.
58. Wingen AM, Fabian-Bach C, Schaefer F, Mehls O. 1997. Randomised multicentre study of a low-protein diet on the progression of chronic renal failure in children. European Study Group of Nutritional Treatment of Chronic Renal Failure in Childhood. Lancet 349(9059):1117-1123.
59. Wong CS, Pierce CB, Cole SR, Warady BA, Mak RH, Benador NM, et al. 2009. Association of proteinuria with race, cause of chronic kidney disease, and glomerular filtration rate in the chronic kidney disease in children study. Clin J Am Soc Nephrol 4(4):812-819.
60. Wong H, Mylrea K, Feber J, Drukker A, Filler G. 2006. Prevalence of complications in children with chronic kidney disease according to KDOQI. Kidney Int 70(3): 585-590.
61. Wuhl E, Mehls O, Schaefer F. 2004. Antihypertensive and antiproteinuric efficacy of ramipril in children with chronic renal failure. Kidney Int 66(2):768-776.
62. Yu CC, Lin JL, Lin-Tan DT. 2004. Environmental exposure to lead and progression of chronic renal diseases: a four-year prospective longitudinal study. J Am Soc Nephrol 15(4):1016-1022.